MedPath

Adefovir dipivoxil

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for .  tablets, for oral use Initial U.S. Approval: 2002

Approved
Approval ID

08e07fae-3191-b6a3-c894-d3a8cc53923f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2023

Manufacturers
FDA

Apotex Corp.

DUNS: 845263701

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

adefovir dipivoxil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-3947
Application NumberANDA205459
Product Classification
M
Marketing Category
C73584
G
Generic Name
adefovir dipivoxil
Product Specifications
Route of AdministrationORAL
Effective DateDecember 1, 2023
FDA Product Classification

INGREDIENTS (6)

ADEFOVIR DIPIVOXILActive
Quantity: 10 mg in 1 1
Code: U6Q8Z01514
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Adefovir dipivoxil - FDA Drug Approval Details